GL1X · GenesisL1 explorer

Research workbench

Factor inhibiting hif-1 alpha in complex with hif-1 alpha fragment peptide

Analyse Factor inhibiting hif-1 alpha in complex with hif-1 alpha fragment peptide in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1H2L
Type
protein
Length
354 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Factor inhibiting HIF1; Hypoxia-inducible factor 1 alpha
UniProt
Q969Q7, Q16665
Ligands
AKG, FE2, SO4
Pockets
5 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 31% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AFactor inhibiting HIF1protein33231% helix, 25% strandQ969Q7
SHypoxia-inducible factor 1 alphaprotein2232% helix, 0% strandQ16665

Ligands and binding sites

  • AKG · 2-oxoglutaric acid · ligand · chains A
  • FE2 · Fe (II) ion · metal · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1760.730.9722FE2, AKG
21520.470.7732empty
3920.460.8028empty
41350.430.7526empty
5930.410.7820empty

Interfaces

1 interface between chains.

  • A–S · 1368 Ų buried · 19 hydrogen bonds · protein-protein

Compared structures

  • 1H2L · Factor Inhibiting HIF-1 alpha in complex with HIF-1 alpha fragment peptide · the same entry in another collection · chain A against A, TM-score 1.00
  • Q16665 · AlphaFold monomer V2.0 prediction for hypoxia-inducible factor 1-alpha (Q16665) · a predicted model of the same protein · chain S against A, TM-score 0.32

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.